ITEM VIEW

Interferon : the clinical experience

dc.contributor.authorVan Helden, P. D.en_ZA
dc.date.accessioned2011-03-18T14:57:41Z
dc.date.available2011-03-18T14:57:41Z
dc.date.issued1983
dc.identifier.issn2078-5135 (online)
dc.identifier.issn0256-9574 (print)
dc.identifier.urihttp://hdl.handle.net/10019.1/7588
dc.descriptionCITATION: Van Helden, P. D. 1983. Interferon : the clinical experience. South African Medical Journal, 63:773-775.
dc.descriptionThe original publication is available at http://www.samj.org.za
dc.description.abstractRecent trials with interferon, in particular those using pure, recombinant interferon, have provided us with improved data (compared with those obtained in early studies) and show that interferon does hold some promise as a therapeutic agent. When used in the treatment of viral disease, interferon has shown itself to be quite effective in reducing viral titres. While not as effective against cancer, interferon has limited tumour growth, reduced the appearance of metastases and led to a general improvement in patient condition in many cases. This article discusses some of the recent results obtained with interferon in the treatment of viral disease and cancer.
dc.format.extent3 pages
dc.language.isoen
dc.publisherHealth & Medical Publishing Group
dc.subjectInterferonen_ZA
dc.titleInterferon : the clinical experienceen_ZA
dc.typeArticle
dc.description.versionPublisher’s version
dc.rights.holderSouth African Medical Journal


Files in this item

Thumbnail

This item appears in the following Collection(s)

ITEM VIEW